INCR (Intercure Ltd. Ordinary Shares) Stock Analysis - AI Report
Intercure Ltd. Ordinary Shares (INCR) is a publicly traded Healthcare sector company. As of May 21, 2026, INCR trades at $0.84 with a market cap of $44.84M and a P/E ratio of -0.47. INCR moved +0.00% today. Year to date, INCR is -17.79%; over the trailing twelve months it is -46.56%. Its 52-week range spans $0.68 to $2.01. Rallies surfaces INCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on INCR?
Rallies AI research for INCR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Gaenzle Christopher L sold 4.68K (~$255.43K) on Sep 18, 2017.
Rush Gregory S sold 9.70K (~$528.60K) on Sep 18, 2017.
Macdonald Alistair sold 2.35K (~$128.20K) on Sep 18, 2017.
INCR Analyst Consensus
INCR analyst coverage data. Average price target: $0.00.
Common questions about INCR
What is the AI research view on INCR?
Rallies AI research for INCR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for INCR?
Rallies AI research for INCR combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is INCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INCR. It does not provide personalized investment advice.
